MG
CSLT

Michael Gelband’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Michael Gelband’s Portfolio CSLT Stock Details CSLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-327,526
Closed -$504K – 2871
2021
Q4 		$504K Buy
327,526
+288,131
+731% +$475K 0.01% 1394
2021
Q3 		$62K Sell
39,395
-2,700
-6% -$5.29K ﹤0.01% 1956
2021
Q2 		$111K Sell
42,095
-295,900
-88% -$551K ﹤0.01% 2129
2021
Q1 		$510K Sell
337,995
-285,646
-46% -$495K 0.01% 1333
2020
Q4 		$811K Buy
623,641
+588,202
+1,660% +$662K 0.01% 976
2020
Q3 		$40K Sell
35,439
-74,264
-68% -$81.6K ﹤0.01% 1643
2020
Q2 		$91K Buy
+109,703
New +$81.5K ﹤0.01% 1643
2019
Q4 		– Sell
-16,471
Closed -$23K – 2014
2019
Q3 		$23K Buy
+16,471
New +$32.8K ﹤0.01% 1288

Michael Gelband's CSLT Position: Q1 2022 in Review

Michael Gelband sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 327,526 shares — an estimated $504K sold.

Michael Gelband first reported a position in CSLT in Q3 2019 and held it in 8 quarters. The position peaked at $811K in Q4 2020. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • Michael Gelband reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • Michael Gelband sold 327,526 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $504K.
  • Michael Gelband first reported a position in CASTLIGHT HEALTH, INC. in Q3 2019 and held it in 8 quarters.
  • Michael Gelband's CASTLIGHT HEALTH, INC. position peaked at $811K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.